• 2002

Company Description

MicroPhage, a diagnostic technology company, develops diagnostic testing for bacterial identification and antibiotic susceptibility.

MicroPhage, Inc., a platform diagnostic technology company, develops medical diagnostics for bacterial identification and antibiotic susceptibility/resistance testing. Its products include methicillin-susceptible Staphylococcus aureus (MSSA)/methicillin-resistant Staphylococcus aureus (MRSA) blood culture tests, MRSA screening tests, and MRSA/MSSA screening tests. The company was founded in 2002 and is based in Longmont, Colorado.